Hyperbilirubinemia is the most common condition requiring evaluation and treatment in
neonates, but for most newborns, it is a benign postnatal transitional phenomenon of no …

BACKGROUND AND OBJECTIVES: Despite the implementation of screening guidelines to
identify infants at risk for hyperbilirubinemia, chronic bilirubin encephalopathy (CBE) …

Jaundice occurs in most newborn infants. Most jaundice is benign, but because of the
potential toxicity of bilirubin, newborn infants must be monitored to identify those who might …

Jaundice occurs in most newborn infants. Most jaundice is benign, but because of the
potential toxicity of bilirubin, newborn infants must be monitored to identify those who might …

Background The neurodevelopmental risks associated with high total serum bilirubin levels
in newborns are not well defined. Methods We identified 140 infants with neonatal total …

Objective Acute bilirubin encephalopathy (ABE) remains one of the important causes of
neonatal mortality and child disability, early identification, and intervention which could …

Objective: To report on the results of a project following term and near term newborn infants
who were jaundiced during the neonatal period. Methods: Neonates were referred to the …

Premature infants have a higher incidence of indirect hyperbilirubinemia than term infants.
Management of neonatal indirect hyperbilirubinemia in late preterm and term neonates has …

Objective: To determine predictors of acute bilirubin encephalopathy (ABE) among term
infants presenting with moderate-to-severe hyperbilirubinaemia. Methods: Babies with total …

Although it is generally believed that preterm infants are at greater risk for the development
of bilirubin-associated brain damage than term infants, quantification of the magnitude of this …